Live Breaking News & Updates on Oncologie Inc

Stay updated with breaking news from Oncologie inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Mereo BioPharma and Cancer Focus Fund Announce Partnership


Mereo BioPharma and Cancer Focus Fund Announce Partnership for Phase 1b/2 Study of Etigilimab in Clear Cell Ovarian Cancer
Study to be Conducted at The University of Texas MD Anderson Cancer Center
Mereo BioPharma Group plc; Cancer Focus Fund
LONDON, UNITED KINGDOM
LONDON and REDWOOD CITY, Calif. and HOUSTON, Texas, April 30, 2021 (GLOBE NEWSWIRE) Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on oncology and rare diseases, and Cancer Focus Fund, LP, a unique venture capital fund established in collaboration with The University of Texas MD Anderson Cancer Center (“MD Anderson”) to provide funding and clinical expertise to advance promising cancer therapies, today announced a partnership to evaluate Mereo’s lead anti-TIGIT therapeutic antibody candidate, etigilimab, in clear cell ovarian cancer, a rare cancer that accounts for approximately 5–10% of ....

United States , City Of , United Kingdom , Barbara Lindheim , Shannon Westin , Christine Fox , Ross Barrett , Lee Roth , Denise Scots Knight , Mereo Biopharma , Cancer Focus Fund , Cancer Focus Fund Contact , Ultragenyx Pharmaceutical Inc , University Of Texas Md Anderson Cancer Center , Mereo Biopharma Group , Feist Weiller Cancer Center Shreveport , Oncologie Inc , Oncxerna Therapeutics Inc , United States Securities Exchange , Partner Of Cancer Focus Fund , Partners For Cancer Focus Fund , Md Anderson Institutional Conflict Of Interest Committee , Biopharma Group , Cancer Center , Gynecologic Oncology , Chief Executive Officer ,